Paracetamolo Coop

Paracetamol, the active ingredient in Paracetamolo Coop, is an analgesic presented as a 500 mg tablet for oral use. It relieves mild to moderate pain and reduces fever in adults and children. GNH USA supplies Paracetamolo Coop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paracetamolo Coop is distributed by GNH USA, a licensed, GDP‑compliant supplier to hospitals, pharmacies and clinics worldwide.

Paracetamolo Coop is an analgesic and antipyretic that acts on common pain‑related pathways and fever mechanisms. - Headache: provides relief of mild to moderate tension‑type or migraine‑associated pain. - Fever: reduces elevated body temperature in infectious or inflammatory states. - Musculoskeletal pain: eases discomfort from strains, sprains and minor joint aches. - Dental pain: alleviates pain following dental procedures or toothache. - Menstrual cramps: helps lessen cramping discomfort associated with menstruation.

Paracetamolo Coop may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: occasional mild stomach upset. - Skin rash: transient erythema or mild itching. - Elevated liver enzymes: mild, reversible changes in liver function tests.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Toxic hepatitis: acute liver injury with jaundice and elevated transaminases. - Anaphylaxis: rapid onset of breathing difficulty, swelling and hypotension. - Blood dyscrasias: rare cases of agranulocytosis or thrombocytopenia.

Paracetamolo Coop should be used with attention to known safety considerations. - Liver disease: avoid or limit use in patients with existing hepatic impairment. - Alcohol use: limit concurrent alcohol intake to reduce hepatotoxic risk. - Pregnancy: use only under medical supervision, especially in the third trimester. - Age: adjust use in children according to pediatric dosing guidelines. - Drug interactions: review concomitant medications for potential CYP450 involvement. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Paracetamolo Coop can interact with several medicines, requiring awareness of the interaction level.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect may raise bleeding risk. - Isoniazid: combined use can heighten risk of liver toxicity.

Moderate Interactions (Monitor Closely): - Antiepileptics (e.g., carbamazepine, phenytoin): may alter paracetamol metabolism. - Alcohol: concurrent use can potentiate hepatotoxicity. - Certain antibiotics (e.g., fluoroquinolones): may increase liver enzyme abnormalities. - HIV protease inhibitors: can affect drug clearance and liver function.